In the present study, we found that combined high expression of SENP1 and HIF2α (SENP1hi/HIF2αhi) is a poor prognostic marker for patients with clear cell renal cell cancer (ccRCC). The gene discussed is EPAS1; the disease is clear cell renal carcinoma.